Curative Biotechnology Inc (CUBT) — Cash Flow-to-Debt Ratio
Curative Biotechnology Inc (CUBT) has a Cash Flow-to-Debt Ratio of -0.02x as of March 2026, meaning its operating cash flow of $-193.12K could theoretically repay 0% of its total liabilities ($8.37 Million) in one year. See Curative Biotechnology Inc (CUBT) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Curative Biotechnology Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Curative Biotechnology Inc across 13 annual periods. For the full cash flow conversion analysis, see CUBT cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Curative Biotechnology Inc (2013–2025)
Year-by-year debt coverage analysis for Curative Biotechnology Inc. Check Curative Biotechnology Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.11x | $-868.87K | $8.20 Million | ▲ +26.7% |
| 2024 | -0.14x | $-1.02 Million | $7.08 Million | ▼ -70.7% |
| 2023 | -0.08x | $-486.58K | $5.75 Million | ▼ -24.7% |
| 2022 | -0.07x | $-1.54 Million | $22.62 Million | ▲ +20.5% |
| 2021 | -0.09x | $-1.60 Million | $18.77 Million | ▼ -205.4% |
| 2020 | -0.03x | $-190.09K | $6.80 Million | ▼ -7305.3% |
| 2019 | 0.00x | $-150.00 | $397.10K | ▼ -84.9% |
| 2018 | 0.00x | $-150.00 | $734.36K | ▲ +2.2% |
| 2017 | 0.00x | $-150.00 | $718.33K | ▲ +97.5% |
| 2016 | -0.01x | $-5.89K | $702.29K | ▼ -394.8% |
| 2015 | 0.00x | $1.96K | $687.16K | ▲ +113.0% |
| 2014 | -0.02x | $-20.99K | $960.99K | ▲ +42.9% |
| 2013 | -0.04x | $-35.68K | $932.66K | — |